178 related articles for article (PubMed ID: 35714719)
21. An LMNA synonymous variant associated with severe dilated cardiomyopathy: Case report.
Gao S; Mumme-Monheit A; Chen SN; Spector EB; Slavov D; Baralle FE; Bristow MR; Mestroni L; Taylor MRG;
Am J Med Genet A; 2022 Feb; 188(2):600-605. PubMed ID: 34652067
[TBL] [Abstract][Full Text] [Related]
22. Modeling Treatment Response for Lamin A/C Related Dilated Cardiomyopathy in Human Induced Pluripotent Stem Cells.
Lee YK; Lau YM; Cai ZJ; Lai WH; Wong LY; Tse HF; Ng KM; Siu CW
J Am Heart Assoc; 2017 Jul; 6(8):. PubMed ID: 28754655
[TBL] [Abstract][Full Text] [Related]
23. Investigating
Shemer Y; Mekies LN; Ben Jehuda R; Baskin P; Shulman R; Eisen B; Regev D; Arbustini E; Gerull B; Gherghiceanu M; Gottlieb E; Arad M; Binah O
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360639
[No Abstract] [Full Text] [Related]
24. Genetic and ultrastructural studies in dilated cardiomyopathy patients: a large deletion in the lamin A/C gene is associated with cardiomyocyte nuclear envelope disruption.
Gupta P; Bilinska ZT; Sylvius N; Boudreau E; Veinot JP; Labib S; Bolongo PM; Hamza A; Jackson T; Ploski R; Walski M; Grzybowski J; Walczak E; Religa G; Fidzianska A; Tesson F
Basic Res Cardiol; 2010 May; 105(3):365-77. PubMed ID: 20127487
[TBL] [Abstract][Full Text] [Related]
25. Genotype Complements the Phenotype: Identification of the Pathogenicity of an LMNA Splice Variant by Nanopore Long-Read Sequencing in a Large DCM Family.
Sedaghat-Hamedani F; Rebs S; Kayvanpour E; Zhu C; Amr A; Müller M; Haas J; Wu J; Steinmetz LM; Ehlermann P; Streckfuss-Bömeke K; Frey N; Meder B
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293084
[TBL] [Abstract][Full Text] [Related]
26. Generation of a human induced pluripotent stem cell line derived from a patient with dilated cardiomyopathy carrying LMNA nonsense mutation.
Shimoda Y; Murakoshi N; Mori H; Xu D; Tajiri K; Hemmi Y; Sato I; Noguchi M; Nakamura Y; Hayashi Y; Ieda M
Stem Cell Res; 2022 Jul; 62():102793. PubMed ID: 35500377
[TBL] [Abstract][Full Text] [Related]
27. In vivo and in vitro examination of the functional significances of novel lamin gene mutations in heart failure patients.
Sylvius N; Bilinska ZT; Veinot JP; Fidzianska A; Bolongo PM; Poon S; McKeown P; Davies RA; Chan KL; Tang AS; Dyack S; Grzybowski J; Ruzyllo W; McBride H; Tesson F
J Med Genet; 2005 Aug; 42(8):639-47. PubMed ID: 16061563
[TBL] [Abstract][Full Text] [Related]
28. Actin-microtubule cytoskeletal interplay mediated by MRTF-A/SRF signaling promotes dilated cardiomyopathy caused by LMNA mutations.
Le Dour C; Chatzifrangkeskou M; Macquart C; Magiera MM; Peccate C; Jouve C; Virtanen L; Heliö T; Aalto-Setälä K; Crasto S; Cadot B; Cardoso D; Mougenot N; Adesse D; Di Pasquale E; Hulot JS; Taimen P; Janke C; Muchir A
Nat Commun; 2022 Dec; 13(1):7886. PubMed ID: 36550158
[TBL] [Abstract][Full Text] [Related]
29. Identification of Target Genes and Transcription Factors in Mice with LMNA-Related Dilated Cardiomyopathy by Integrated Bioinformatic Analyses.
Zhou H; Tan L; Lu T; Xu K; Li C; Liu Z; Peng H; Shi R; Zhang G
Med Sci Monit; 2020 Jun; 26():e924576. PubMed ID: 32581210
[TBL] [Abstract][Full Text] [Related]
30. Amelioration of desmin network defects by αB-crystallin overexpression confers cardioprotection in a mouse model of dilated cardiomyopathy caused by LMNA gene mutation.
Galata Z; Kloukina I; Kostavasili I; Varela A; Davos CH; Makridakis M; Bonne G; Capetanaki Y
J Mol Cell Cardiol; 2018 Dec; 125():73-86. PubMed ID: 30342008
[TBL] [Abstract][Full Text] [Related]
31. Lamin A/C mutation is independently associated with an increased risk of arterial and venous thromboembolic complications.
van Rijsingen IA; Bakker A; Azim D; Hermans-van Ast JF; van der Kooi AJ; van Tintelen JP; van den Berg MP; Christiaans I; Lekanne Dit Deprez RH; Wilde AA; Zwinderman AH; Meijers JC; Grootemaat AE; Nieuwland R; Pinto YM; Pinto-Sietsma SJ
Int J Cardiol; 2013 Sep; 168(1):472-7. PubMed ID: 23073275
[TBL] [Abstract][Full Text] [Related]
32. Pathogenic LMNA variants disrupt cardiac lamina-chromatin interactions and de-repress alternative fate genes.
Shah PP; Lv W; Rhoades JH; Poleshko A; Abbey D; Caporizzo MA; Linares-Saldana R; Heffler JG; Sayed N; Thomas D; Wang Q; Stanton LJ; Bedi K; Morley MP; Cappola TP; Owens AT; Margulies KB; Frank DB; Wu JC; Rader DJ; Yang W; Prosser BL; Musunuru K; Jain R
Cell Stem Cell; 2021 May; 28(5):938-954.e9. PubMed ID: 33529599
[TBL] [Abstract][Full Text] [Related]
33. Lamin A/C mutations in dilated cardiomyopathy.
Tesson F; Saj M; Uvaize MM; Nicolas H; Płoski R; Bilińska Z
Cardiol J; 2014; 21(4):331-42. PubMed ID: 24846508
[TBL] [Abstract][Full Text] [Related]
34. Quantitative expression of the mutated lamin A/C gene in patients with cardiolaminopathy.
Narula N; Favalli V; Tarantino P; Grasso M; Pilotto A; Bellazzi R; Serio A; Gambarin FI; Charron P; Meder B; Pinto Y; Elliott PM; Mogensen J; Bolognesi M; Bollati M; Arbustini E
J Am Coll Cardiol; 2012 Nov; 60(19):1916-20. PubMed ID: 23062543
[TBL] [Abstract][Full Text] [Related]
35. LMNA mutations in Polish patients with dilated cardiomyopathy: prevalence, clinical characteristics, and in vitro studies.
Saj M; Bilinska ZT; Tarnowska A; Sioma A; Bolongo P; Sobieszczanska-Malek M; Michalak E; Golen D; Mazurkiewicz L; Malek L; Walczak E; Fidzianska A; Grzybowski J; Przybylski A; Zielinski T; Korewicki J; Tesson F; Ploski R
BMC Med Genet; 2013 May; 14():55. PubMed ID: 23702046
[TBL] [Abstract][Full Text] [Related]
36. Expression of Lmna-R225X nonsense mutation results in dilated cardiomyopathy and conduction disorders (DCM-CD) in mice: Impact of exercise training.
Cai ZJ; Lee YK; Lau YM; Ho JC; Lai WH; Wong NL; Huang D; Hai JJ; Ng KM; Tse HF; Siu CW
Int J Cardiol; 2020 Jan; 298():85-92. PubMed ID: 31668660
[TBL] [Abstract][Full Text] [Related]
37. Expanding the phenotype of LMNA mutations in dilated cardiomyopathy and functional consequences of these mutations.
Sébillon P; Bouchier C; Bidot LD; Bonne G; Ahamed K; Charron P; Drouin-Garraud V; Millaire A; Desrumeaux G; Benaïche A; Charniot JC; Schwartz K; Villard E; Komajda M
J Med Genet; 2003 Aug; 40(8):560-7. PubMed ID: 12920062
[TBL] [Abstract][Full Text] [Related]
38. Integrated analysis reveals the alterations that LMNA interacts with euchromatin in LMNA mutation-associated dilated cardiomyopathy.
Zhang X; Shao X; Zhang R; Zhu R; Feng R
Clin Epigenetics; 2021 Jan; 13(1):3. PubMed ID: 33407844
[TBL] [Abstract][Full Text] [Related]
39. BET bromodomain inhibition attenuates cardiac phenotype in myocyte-specific lamin A/C-deficient mice.
Auguste G; Rouhi L; Matkovich SJ; Coarfa C; Robertson MJ; Czernuszewicz G; Gurha P; Marian AJ
J Clin Invest; 2020 Sep; 130(9):4740-4758. PubMed ID: 32484798
[TBL] [Abstract][Full Text] [Related]
40. Expression of an LMNA-N195K variant of A-type lamins results in cardiac conduction defects and death in mice.
Mounkes LC; Kozlov SV; Rottman JN; Stewart CL
Hum Mol Genet; 2005 Aug; 14(15):2167-80. PubMed ID: 15972724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
